SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001062993-23-001043
Filing Date
2023-01-19
Accepted
2023-01-18 18:15:42
Documents
7

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 17620
2 PART II AND III form1aa.htm PART II AND III 908028
3 EXHIBIT 6.3 exhibit1a6-3.htm EX1A-6 MAT CTRCT 26710
4 EXHIBIT 11.1 exhibit1a11-1.htm EX1A-11 CONSENT 1364
5 exhibit1a6-3x002.jpg GRAPHIC 2493
6 exhibit1a6-3x003.jpg GRAPHIC 2065
7 exhibit1a6-3x001.jpg GRAPHIC 3960
  Complete submission text file 0001062993-23-001043.txt   966902
Mailing Address 400-601 WEST BROADWAY VANCOUVER A1 V5Z 4C2
Business Address 400-601 WEST BROADWAY VANCOUVER A1 V5Z 4C2 (604) 398-4175
Algernon Neuroscience Inc. (Filer) CIK: 0001959708 (see all company filings)

IRS No.: 785435413 | State of Incorp.: A1 | Fiscal Year End: 0831
Type: 1-A/A | Act: 33 | File No.: 024-12117 | Film No.: 23535440
SIC: 2834 Pharmaceutical Preparations